NCT04384250CompletedNot Applicable
Genetic Factors Influencing the Response to Infection with SARS-COV-2
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Mansoura University
- Enrollment
- 500
- Locations
- 1
- Primary Endpoint
- Mutations leading to increase susceptibility to SARS-COV-2 infection
Study Overview
Brief Summary
We will study genetic factors causing severe disease due to infection with SARS-COV-2 which may help to find targeted therapy
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 1 Day to 50 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •severe COVID-19 infection
Exclusion Criteria
- •Comorbidity ((DM, hypertension, Chronic liver or Kidney diseases, HIV, morbid obesity, Malignancy, Immunosuppressive therapy)
Outcomes
Primary Outcomes
Mutations leading to increase susceptibility to SARS-COV-2 infection
Time Frame: 12 months
Genetic susceptibility to COVID-19
Secondary Outcomes
No secondary outcomes reported
Investigators
Ali Sobh
Lecturer of Pediatric Immunology
Mansoura University
Study Sites (1)
Loading locations...
Similar Trials
Active, not recruiting
Not Applicable
Genotype and Susceptibility to COVID-19Covid19NCT04799834Mario Negri Institute for Pharmacological Research1,200
Unknown
Not Applicable
Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive FunctionCovid19NCT04506229Texas Cardiac Arrhythmia Research Foundation60
Completed
Not Applicable
Genetics of COVID-19 Susceptibility and ManifestationsCoronavirus 2019COVID-19NCT04371432National Human Genome Research Institute (NHGRI)721
Unknown
Not Applicable
Impact of the Genetic Polymorphism on COVID-19 in EgyptCOVID-19NCT05157217Cairo University98
Unknown
Not Applicable
Genetic Predisposition to Severe Forms of COVID-19 (SARS-CoV2 Infection)Covid19NCT04644146Hospices Civils de Lyon40